I

Immatics NV
D

IMTX

9.41000
USD
0.68
(7.73%)
مغلق
حجم التداول
108,680
الربح لكل سهم
0
العائد الربحي
-
P/E
-14
حجم السوق
1,143,874,961
أصول ذات صلة الأخبار المقالات

العنوان: Immatics NV

القطاع: Healthcare
الصناعة: Biotechnology
Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.